The Effects of Fasting on Patient Outcomes in Local-Only Procedures

Sponsor
University of California, Irvine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05819801
Collaborator
(none)
134
2
31

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether eating solid food prior to undergoing a wide awake local-only no tourniquet (WALANT) procedure reduces anxiety in patients or has any effect on outcomes. Patients will be split randomly into two groups and told whether to eat or fast before their procedure. We will then compare levels of anxiety and nausea on the day of the procedure as well as satisfaction with the procedure and other outcome measures at follow-up visits. Our hypothesis is that patients who are instructed to eat before their WALANT procedure will have less anxiety, nausea, and overall higher satisfaction compared to those who are instructed to fast prior to their procedure.

Condition or Disease Intervention/Treatment Phase
  • Other: Non-fasting
  • Other: Fasting
N/A

Detailed Description

Patients will initially present for preoperative evaluation in clinic, where informed consent will be obtained prior to them being enrolled in the study. If they choose to participate, they will be assigned either to the eating group or the fasting group. Patients in the fasting group will be told to avoid any food past midnight the day before their surgery and any liquids 4 hours before their scheduled surgery. The eating group will be told specifically to eat a light meal (equivalent to two slices of toasted bread with butter and jam, and one cup of coffee or juice) the morning of their surgery, within two hours of their procedure start time. All their other preoperative instructions will be consistent with the current protocols.

On their day of surgery, they will present to the hospital at the pre-arranged time. They will be taken to the preoperative area, where they will be treated in the standard way to prepare them for any procedure. While in the preoperative area, they will be asked whether they ate solid food prior to arrival. They will also be assessed using the Amsterdam Preoperative Anxiety and Information Score and preoperative pain/nausea visual analog score. Heart rate, blood pressure, and body mass index will also be collected. They will then undergo their procedure the same way regardless of whether they ate.

Postoperatively, they will be taken to the recovery room. There, they will again be assessed using the Amsterdam Preoperative Anxiety and Information Score and postoperative pain/nausea visual analog score. Heart rate and blood pressure will also be collected at this time.

Patients will be followed at regular intervals following their procedure at 2 weeks and 6 weeks. At their first postoperative visit, patients will be assessed using the surgical satisfaction-8 scores.

Patients will also be given the Disabilities of the Arm, Shoulder, and Hand (QuickDASH) to complete at their second postoperative visit at approximately 6 weeks.

Patient data will be collected until 6 months post operatively. Complications such as wound healing, infections, medication side effects will be included in data collection, these will be collected from medical records only and no further study surveys or interventions will be performed after the second postoperative visit.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
134 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients will be randomly divided into two groups and told whether to eat or fast prior to their procedurePatients will be randomly divided into two groups and told whether to eat or fast prior to their procedure
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effects of Fasting on Patient Outcomes in Local-Only Procedures
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2026
Anticipated Study Completion Date :
Jan 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Fasting

Patients in the fasting group will be told to avoid any food past midnight the day before their surgery and any liquids 4 hours before their scheduled surgery.

Other: Fasting
Instructing patients to fast before their local-only procedure

Experimental: Not Fasting

The eating group will be told specifically to eat a light meal (equivalent to two slices of toasted bread with butter and jam and one cup of coffee or juice) the morning of their surgery, within two hours of their procedure start time.

Other: Non-fasting
Instructing patients to eat before their local-only procedure

Outcome Measures

Primary Outcome Measures

  1. Amsterdam Preoperative Anxiety and Information Score [Prior to and immediately following the procedure]

    Measure of anxiety

Secondary Outcome Measures

  1. Heart rate [Prior to and immediately following the procedure]

    Measure of heart rate

  2. Blood pressure [Prior to and immediately following the procedure]

    Measure of blood pressure

  3. Hunger scale [Prior to and immediately following the procedure]

    Visual analog scale of hunger

  4. Thirst scale [Prior to and immediately following the procedure]

    Visual analog scale of thirst

  5. Nausea scale [Prior to and immediately following the procedure]

    Visual analog scale of nausea

  6. Pain scale [Prior to and immediately following the procedure]

    Visual analog scale of pain

  7. Surgical Satisfaction - 8 Score [Approximately 2 weeks after the procedure]

    Measure of satisfaction with the procedure

  8. QuickDASH Score [Approximately 6 weeks after the procedure]

    Measure of functional status of the upper extremity

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing wide-awake, local anesthetic-only, no-tourniquet (WALANT) procedures with the lead researcher.
Exclusion Criteria:
  • Patients with insulin-dependent diabetes or allergy to local anesthesia, < 18 years of age, patients unable to follow up.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of California, Irvine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jesse Kaplan, Assistant Clinical Professor, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT05819801
Other Study ID Numbers:
  • IRB# 2157
First Posted:
Apr 19, 2023
Last Update Posted:
Apr 19, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 19, 2023